Cargando…
Vitamin K epoxide reductase regulation of androgen receptor activity
Long-term use of warfarin has been shown to be associated with a reduced risk of prostate cancer. Warfarin belongs to the vitamin K antagonist class of anticoagulants, which inhibit vitamin K epoxide reductase (VKOR). The vitamin K cycle is primarily known for its role in γ-carboxylation, a rare pos...
Autores principales: | Tew, Ben Yi, Hong, Teresa B., Otto-Duessel, Maya, Elix, Catherine, Castro, Egbert, He, Miaoling, Wu, Xiwei, Pal, Sumanta K., Kalkum, Markus, Jones, Jeremy O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355141/ https://www.ncbi.nlm.nih.gov/pubmed/28099154 http://dx.doi.org/10.18632/oncotarget.14639 |
Ejemplares similares
-
Identification of neuron selective androgen receptor inhibitors
por: Otto-Duessel, Maya, et al.
Publicado: (2017) -
Structure of a bacterial homolog of vitamin K epoxide reductase
por: Li, Weikai, et al.
Publicado: (2010) -
Androgen Receptor and PI3K Pathway Activity in Ovarian Cancer
por: Hill, Addie, et al.
Publicado: (2019) -
Human Vitamin K Epoxide Reductase as a Target of Its Redox Protein
por: Ledoux, Julie, et al.
Publicado: (2022) -
Mechanistic Investigation of the Androgen Receptor
DNA-Binding Domain Inhibitor Pyrvinium
por: Pal, Sumanta K., et al.
Publicado: (2019)